MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Israel Medical Association journal : IMAJ · 2020

Advanced Lung Disease in Patients with Cystic Fibrosis Is Associated with Low Diffusion capacity.

Vilozni Daphna, Dagan Adi, Sarouk Ifat, Bar-Aluma Bat-El, Ashkenazi Moshe, Bezalel Yael, Efrati Ori

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The single-breath diffusing capacity of the lungs (DLCOSB) test measures the extent to which carbon monoxide (CO) passes from the lung air sacs into the blood. The accessible alveolar volume (VASB) is measured by inert gas during a 10-second period. The single-breath transfer coefficient of the lung for carbon monoxide (KCOSB) is the DLCOSB divided by VASB. Cystic fibrosis (CF) disease comprises progressive airway obstruction with bronchiectasis and parenchyma fibrosis. Yet, the KCOSB appears insignificant in the assessment of pulmonary function in CF.

OBJECTIVES

To challenge the precision of normal KCOSB in CF.

METHODS

The authors collected pulmonary function tests (PFT) data from 74 confirmed CF patients (mean age 26 ± 10 years) with various levels of pulmonary disease severity. Tests included spirometry, DLCOBP, and body plethysmography (BP). Anatomical dead space was calculated by deducting anatomical dead space from total lung capacity TLC(BP) to establish alveolar volume (VABP) and to determine KCOBP. We also included individual data of arterial pCO2 blood-gas level.

RESULTS

KCOSB values were normal or higher in most patients, regardless of patient FEV1 value (R2 = 0.2204; P < 0.02). In contrast, the measurements of KCOBP were low corresponding with low FEV1 values, and negatively correlated with the elevation of trapped air and pCO2 levels (R2 = 0.1383; P = 0.0133, P > 0.05, respectively).

CONCLUSIONS

The 10- second perfusion time of the inert gas during DLCOSB represent the communicative alveolar volume in CF patients with advanced pulmonary disease. The findings justify the use of DLCOSB with the deterioration of FEV1 and elevation of pCO2 levels.

Для цитирования: Vilozni Daphna, Dagan Adi, Sarouk Ifat, Bar-Aluma Bat-El, Ashkenazi Moshe, Bezalel Yael, Efrati Ori. Advanced Lung Disease in Patients with Cystic Fibrosis Is Associated with Low Diffusion capacity.. The Israel Medical Association journal : IMAJ. 2020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.